Philip Nichols of the Wharton School discusses corporate corruption.
School of Veterinary Medicine
András Komáromy of the School of Veterinary Medicine and fellow researchers use gene therapy to treat blindness.
Gene Therapy Success Sets Stage for New Treatments for Inherited Blindness, Penn Veterinary Researchers Say
PHILADELPHIA –- Veterinary vision scientists at the University of Pennsylvania have safely and successfully used a viral vector in targeting a class of photoreceptors of the retina called rods, a critical first step in developing gene therapies for inherited blindness caused by rod degeneration.
John Gearhart of the School of Veterinary Medicine and the School of Medicine discusses a Vatican-sponsored stem-cell research study.
PHILADELPHIA –- Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy or total color blindness.
Double Agents: Penn Researchers Identify Immune Cells That Fight Parasites May Promote Allergies and Asthma
PHILADELPHIA –- Millions of people in both the developing and developed world may benefit from new immune-system research findings from the University of Pennsylvania School of Veterinary Medicine.
The Penn Vet researchers, studying how the immune system operates, have discovered a previously unidentified cell population that may be the body’s double-edged sword, fighting off parasitic infections but also causing the harmful immune responses that can lead to allergies and asthma.